Q3 2013

Filed Nov 4, 2013 · 10-Q · 35 days after period end · 0000877860-13-000101

Q3 2013 · 10-Q

Revenue

$30.85M

+31.8% vs Q3 2012

Net Income

$42.74M

+197.8% vs Q3 2012

EPS Diluted

$1.53

+194.2% vs Q3 2012

Operating Income$23,118,000+61.1%

Operating Cash Flow

Same quarter

Metric	Q3 2013	Q3 2012	Q3 2011	Q3 2010
Revenue	$30.85M	$23.40M	$21.58M	$19.42M
Net Income	$42.74M	$14.35M	$18.81M	$17.33M
EPS Diluted	$1.53	$0.52	$0.68	$0.62

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR